Serina Therapeutics, Inc. (SER) › Shareholders' EquitySerina Therapeutics, Inc. (SER) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$22.38M2017: $8.32M2018: $8.23M2019: $2.62M2020: -$5.40M2021: -$11.88M2022: -$37.78M2023: -$32.29M2024: $508.0K2025: -$37.0K-$37.0K2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$37.0K-107.3%2024$508.0K+101.6%2023-$32.29M+14.5%2022-$37.78M-218.1%2021-$11.88M-120.1%2020-$5.40M-306.2%2019$2.62M-68.2%2018$8.23M-1.1%2017$8.32M+137.2%2016-$22.38M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share